These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 7712686)

  • 1. Pancreatic reserve and insulin dose in type 2 diabetic patients.
    Calle JR; Rubio MA; Calle-Pascual AL; Bordiu E; Marañés JP
    Diabetes Res; 1993; 23(3):123-9. PubMed ID: 7712686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of pancreatic insulin reserve on the metabolic control of type I and II diabetes mellitus].
    Calle Fernández JR; Rubio Herrera MA; Calle Pascual AL; Bordíu Obanza E; Marañes Pallardo JP
    An Med Interna; 1994 Jul; 11(7):322-7. PubMed ID: 7981358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The utility of postprandial C-peptide evaluation in type 2 diabetes].
    Prando R; Giusti R; Ciuchi E; Giusto M; Melga PL; Cheli V
    Riv Eur Sci Med Farmacol; 1996; 18(3):95-104. PubMed ID: 9213846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
    Rattarasarn C; Thamprasit A; Leelawattana R; Soonthornpun S; Setasuban W
    J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta cell function in long term NIDDM (type 2) patients and its relation to treatment.
    Snehalatha C; Ramachandran A; Mohan V; Timothy H; Viswanathan M
    Horm Metab Res; 1986 Jun; 18(6):391-4. PubMed ID: 3525362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The level of 2-h post-challenge glucose is an independent risk factor of carotid intima-media thickness progression in Korean type 2 diabetic patients.
    Kim HJ; Ahn CW; Kang ES; Myoung SM; Cha BS; Won YJ; Lim SK; Kim KR; Huh KB; Lee HC
    J Diabetes Complications; 2007; 21(1):7-12. PubMed ID: 17189868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
    Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
    Meneghini L; Koenen C; Weng W; Selam JL
    Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
    Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
    Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group.
    Schiel R; Müller UA; Rauchfub J; Sprott H; Müller R
    Diabetes Metab; 1999 Sep; 25(4):334-40. PubMed ID: 10566123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Added benfluorex in obese insulin-requiring type 2 diabetes.
    Leutenegger M; Bauduceau B; Brun JM; Guillon-Metz F; Martin C; Nicolino-Peltier C; Richard JL; Vannereau D
    Diabetes Metab; 1998 Feb; 24(1):55-61. PubMed ID: 9534010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
    Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin effects on glucose kinetics in non-insulin-dependent diabetic patients with secondary failure to hypoglycaemic agents: role of different modes and rates of delivery.
    Paolisso G; Sgambato S; Varricchio M; Scheen AJ; D'Onofrio F; Lefèbvre P
    Eur J Med; 1992 Sep; 1(5):261-7. PubMed ID: 1341607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic beta cell response in insulin treated NIDDM patients limitations of a random C-peptide measurement.
    Snehalatha C; Ramachandran A; Mohan V; Viswanathan M
    Diabete Metab; 1987 Feb; 13(1):27-30. PubMed ID: 3552773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beneficial effects of added glicazide in patients with type II diabetes mellitus treated with insulin].
    Ruas MM; Carvalheiro M; Geraldes E; Carrilho F; Bastos M; Fagulha A; Paiva I; Rodrigues F; Gomes L
    Acta Med Port; 1991; 4(2):76-8. PubMed ID: 1867120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pancreatic reserve in diabetes mellitus by the determination of serum C-peptide using radioimmunoassay].
    Arteaga A; Velasco N; Szegedi AM; Pellegrino MR; López G; Foradori A; Acosta AM
    Rev Med Chil; 1984 Apr; 112(4):321-9. PubMed ID: 6385178
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modern insulin injection aids in type II diabetic patients].
    Möhrle W; Richter WO; Schwandt P
    Fortschr Med; 1989 Feb; 107(4):53-4, 59-60. PubMed ID: 2647602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of liver echogenicity is correlated to serum c-peptide levels in type 2 diabetic patients.
    Papanas N; Symeonidis G; Mavridis G; Papazoglou D; Giannakis I; Papatheodorou K; Pastore F; Lakasas G; Maltezos E
    Acta Clin Belg; 2006; 61(1):5-9. PubMed ID: 16673610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.